Differential proteomic analysis of endemic and sporadic Epstein–Barr virus-positive and negative Burkitt lymphoma. Issue 1 (January 2015)
- Record Type:
- Journal Article
- Title:
- Differential proteomic analysis of endemic and sporadic Epstein–Barr virus-positive and negative Burkitt lymphoma. Issue 1 (January 2015)
- Main Title:
- Differential proteomic analysis of endemic and sporadic Epstein–Barr virus-positive and negative Burkitt lymphoma
- Authors:
- El-Mallawany, Nader Kim
Day, Nancy
Ayello, Janet
Van de Ven, Carmella
Conlon, Kevin
Fermin, Damian
Basrur, Venkatesha
Elenitoba-Johnson, Kojo
Lim, Megan
Cairo, Mitchell S. - Abstract:
- <abstract xml:lang="en" abstract-type="author" id="ab005"> <title id="st095">Abstract</title> <sec> <title id="st100">Background</title> <p id="sp0005">Burkitt lymphoma (BL) is the most common non-Hodgkin lymphoma in children worldwide and the most common paediatric malignancy in sub-Saharan Africa. The endemic (eBL) and sporadic (sBL) variants have distinct epidemiologic and virologic characteristics. Although gene expression studies have defined the transcriptional profiles of both, their proteomic signatures have not been studied.</p> </sec> <sec> <title id="st105">Methods</title> <p id="sp0010">We compared the proteomic expression profiles using differential mass spectrometry-based isotope tag for relative and absolute quantitation (iTRAQ) analysis of a cell line representing Epstein–Barr virus (EBV)+ eBL, EBV+ and EBV– sBL, and EBV+/– normal B cells from healthy donors.</p> </sec> <sec> <title id="st110">Results</title> <p id="sp0015">In total, there were 144 differentially expressed proteins with a statistically significant false discovery rate (FDR) of ⩽0.2. Results revealed over-expression of specific proteins with well-established links to lymphomagenesis such as TUBB2C (FDR 0.05), UCHL1 (FDR 0.05) and HSP90AB1 (FDR 0.1). Distinct characteristics based upon the epidemiologic and virologic subtypes of BL were also identified. In sBL, PCNA (FDR 0.05) and SLC3A2 (FDR 0.1) were significantly over-expressed. In eBL, C1QBP (FDR 0.1) and ENO1 (FDR 0.25) were significantly<abstract xml:lang="en" abstract-type="author" id="ab005"> <title id="st095">Abstract</title> <sec> <title id="st100">Background</title> <p id="sp0005">Burkitt lymphoma (BL) is the most common non-Hodgkin lymphoma in children worldwide and the most common paediatric malignancy in sub-Saharan Africa. The endemic (eBL) and sporadic (sBL) variants have distinct epidemiologic and virologic characteristics. Although gene expression studies have defined the transcriptional profiles of both, their proteomic signatures have not been studied.</p> </sec> <sec> <title id="st105">Methods</title> <p id="sp0010">We compared the proteomic expression profiles using differential mass spectrometry-based isotope tag for relative and absolute quantitation (iTRAQ) analysis of a cell line representing Epstein–Barr virus (EBV)+ eBL, EBV+ and EBV– sBL, and EBV+/– normal B cells from healthy donors.</p> </sec> <sec> <title id="st110">Results</title> <p id="sp0015">In total, there were 144 differentially expressed proteins with a statistically significant false discovery rate (FDR) of ⩽0.2. Results revealed over-expression of specific proteins with well-established links to lymphomagenesis such as TUBB2C (FDR 0.05), UCHL1 (FDR 0.05) and HSP90AB1 (FDR 0.1). Distinct characteristics based upon the epidemiologic and virologic subtypes of BL were also identified. In sBL, PCNA (FDR 0.05) and SLC3A2 (FDR 0.1) were significantly over-expressed. In eBL, C1QBP (FDR 0.1) and ENO1 (FDR 0.25) were significantly over-expressed. Comparison of EBV+ to EBV– BL cell lines and B cells revealed significant over-expression of DDX3X (FDR 0.1). Proteins were validated using Western blot analysis.</p> </sec> <sec> <title id="st115">Conclusion</title> <p id="sp0020">Our results suggest unique signal transduction pathways associated with EBV infection and epidemiological subtype of BL that may contribute to lymphomagenesis. These proteomic findings provide potential diagnostic, prognostic and therapeutic links to BL.</p> </sec> </abstract> … (more)
- Is Part Of:
- European journal of cancer. Volume 51:Issue 1(2015:Jan.)
- Journal:
- European journal of cancer
- Issue:
- Volume 51:Issue 1(2015:Jan.)
- Issue Display:
- Volume 51, Issue 1 (2015)
- Year:
- 2015
- Volume:
- 51
- Issue:
- 1
- Issue Sort Value:
- 2015-0051-0001-0000
- Page Start:
- 92
- Page End:
- 100
- Publication Date:
- 2015-01
- Subjects:
- Cancer -- Periodicals
Neoplasms -- Periodicals
Cancer -- Périodiques
Cancer
Tumors
Electronic journals
Periodicals
Electronic journals
616.994 - Journal URLs:
- http://www.sciencedirect.com/science/journal/09598049 ↗
http://rzblx1.uni-regensburg.de/ezeit/warpto.phtml?colors=7&jour_id=2879 ↗
http://www.clinicalkey.com/dura/browse/journalIssue/09598049 ↗
http://www.clinicalkey.com.au/dura/browse/journalIssue/09598049 ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/j.ejca.2014.10.017 ↗
- Languages:
- English
- ISSNs:
- 0959-8049
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3829.725100
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 4218.xml